Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
AVADEL PHARMACEUTICALS PLC (AVDL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "AVADEL PHARMACEUTICALS PLC CONDENSED CONSOLIDATED STATEMENTS OF LOSS"
08/03/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
08/03/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDMENT TO THE AVADEL PHARMACEUTICALS PLC 2020 OMNIBUS INCENTIVE COMPENSATION PLAN"
05/31/2023 8-K Other Events  Interactive Data
05/04/2023 8-K Quarterly results
04/05/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Execution Version AVADEL FINANCE CAYMAN LIMITED, as Notes Issuer AND AVADEL PHARMACEUTICALS PLC, as Guarantor AND THE BANK OF NEW YORK MELLON, as Trustee INDENTURE Dated as of April 3, 2023 6.00% Exchangeable Senior Notes due 2027"
04/03/2023 8-K Other Events  Interactive Data
03/30/2023 8-K Quarterly results
03/29/2023 8-K Quarterly results
03/22/2023 8-K Quarterly results
03/02/2023 8-K Other Events  Interactive Data
02/24/2023 8-K Other Events  Interactive Data
02/01/2023 8-K Quarterly results
11/18/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Avadel Pharmaceuticals Announces Favorable Ruling on Motion to Delist REMS Patent from FDA’ s Orange Book"
11/09/2022 8-K Quarterly results
11/04/2022 8-K Quarterly results
09/30/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/25/2022 8-K Other Events  Interactive Data
08/09/2022 8-K Quarterly results
08/05/2022 8-K Quarterly results
07/22/2022 8-K Quarterly results
07/19/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
05/26/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
04/26/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
04/15/2022 8-K Other Events  Interactive Data
04/05/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Indenture, by and between the Issuer, the Company and The Bank of New York Mellon, as Trustee"
03/17/2022 8-K Quarterly results
Docs: "Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results"
03/16/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Form of Exchange Agreement between the Issuer, the Company and certain holders of the Existing Notes"
03/11/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Avadel Announces New Positive Data for Once-at-Bedtime FT218 for Narcolepsy and Once-Nightly Dosing Preference Among Patients and Clinicians at World Sleep 2022"
11/08/2021 8-K Quarterly results
Docs: "Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results"
10/19/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Avadel Presents New Data Supporting Clinical Benefit with Once-at-Bedtime FT218 and Preference for Once-Nightly Dosing in Patients with Narcolepsy at CHEST 2021"
10/18/2021 8-K Regulation FD Disclosure  Interactive Data
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy